Chief Scientific Officer of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), Bradshaw Curt, sells 15,625 shares worth $1,073,906

According to Arrowhead Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 23 05:58 PM, company Chief Scientific Officer, Bradshaw Curt disclosed selling 15,625 shares at a cost of $68.73. At the time of this transaction (Nov 20), this trade was worth $1,073,906 in total. As of Nov 20, Bradshaw Curt now owns 0 shares in total worth about $0.0.

For the last few recent trades made by Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Chief Scientific Officer, Bradshaw Curt, we have the following information:

Posted by George Daniels on Monday November 23 2020, 10:12 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0